Impact of Rituximab on Immunoglobulin Concentrations and B Cell Numbers after Cyclophosphamide Treatment in Patients with ANCA-Associated Vasculitides
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of Rituximab on Immunoglobulin Concentrations and B Cell Numbers after Cyclophosphamide Treatment in Patients with ANCA-Associated Vasculitides
Authors
Keywords
B cells, Antibodies, Immunosuppressives, Wegener granulomatosis, Cyclophosphamide, Enzyme-linked immunoassays, Vaccination and immunization, Polysaccharides
Journal
PLoS One
Volume 7, Issue 5, Pages e37626
Publisher
Public Library of Science (PLoS)
Online
2012-05-22
DOI
10.1371/journal.pone.0037626
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations
- (2011) Julia U Holle et al. ANNALS OF THE RHEUMATIC DISEASES
- B cell reconstitution and T helper cell balance after rituximab treatment of active primary Sjögren's syndrome: A double-blind, placebo-controlled study
- (2011) W. H. Abdulahad et al. ARTHRITIS AND RHEUMATISM
- Pathogenesis of ANCA-Associated Vasculitis, an Update
- (2011) Cees G. M. Kallenberg CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Long-term follow-up of different refractory systemic vasculitides treated with rituximab
- (2011) Frances Rees et al. CLINICAL RHEUMATOLOGY
- Prolonged disease-free remission following rituximab and low-dose cyclophosphamide therapy for renal ANCA-associated vasculitis
- (2011) N. Mansfield et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis
- (2011) M.-J. C. J. Guerry et al. RHEUMATOLOGY
- Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry
- (2010) J.-E. Gottenberg et al. ARTHRITIS AND RHEUMATISM
- The American College of Rheumatology 1990 criteria for the classification of vasculitis: Introduction
- (2010) Gene G. Hunder et al. ARTHRITIS AND RHEUMATISM
- The American College of Rheumatology 1990 criteria for the classification of wegener's granulomatosis
- (2010) Randi Y. Leavitt et al. ARTHRITIS AND RHEUMATISM
- The American College of Rheumatology 1990 criteria for the classification of churg-strauss syndrome (allergic granulomatosis and angiitis)
- (2010) Alfonse T. Masi et al. ARTHRITIS AND RHEUMATISM
- Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte homeostasis
- (2010) Erika Irie et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials
- (2010) R. F. van VOLLENHOVEN et al. JOURNAL OF RHEUMATOLOGY
- Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
- (2010) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
- (2010) Rachel B. Jones et al. NEW ENGLAND JOURNAL OF MEDICINE
- A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis
- (2009) Rachel B. Jones et al. ARTHRITIS AND RHEUMATISM
- Profound Hypogammaglobulinemia 7 Years after Treatment for Indolent Lymphoma
- (2008) Alison R. Walker et al. CANCER INVESTIGATION
- Rituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production
- (2008) R. J. Pepper et al. RHEUMATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now